Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
申请人:THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services, Office of Technology Transfer, National Institutes of Health
公开号:US10590074B2
公开(公告)日:2020-03-17
Disclosed herein are bisarylmethylthioacetamides and bisarylmethylthioethylamines useful as inhibitors of monoamine transporters. The compounds are potent and/or selective inhibitors of dopamine (DA), serotonin (5-HT), and/or norepinephrine (NE) reuptake via their respective transporters, DAT, SERT and NET. Also disclosed are methods for eliciting a wake-promoting or cognitive or attention enhancing effect and for treating substance use disorders, attention deficit (hyperactivity) disorder, depressive disorders, bipolar disorder or other neuropsychiatric disorders sleep disorders or cognitive impairment using the compounds.
本文公开了可用作单胺转运体抑制剂的双芳基甲硫基乙酰胺和双芳基甲硫基乙胺。这些化合物是多巴胺(DA)、5-羟色胺(5-HT)和/或去甲肾上腺素(NE)通过各自的转运体 DAT、SERT 和 NET 再摄取的强效和/或选择性抑制剂。此外,还公开了利用这些化合物激发促进觉醒或认知或注意力增强效应以及治疗药物使用障碍、注意力缺陷(多动)症、抑郁症、双相情感障碍或其他神经精神疾病睡眠障碍或认知障碍的方法。